Pic: Getty Images
share
Stockhead’s Top 10 at 10, published at ~10.30am each trading day, highlights the best (and worst) performing ASX stocks in morning trade using live data.
It’s a short, sharp update to help frame the trading day by showing the biggest movers in percentage terms.
The market opens at 10am (eastern time) and the data is taken at 10:15am, once every ASX stock has started trading.
WINNERS
Stocks highlighted in yellow have made market-moving announcements (click headings to sort).
| Code | Description | Last | % | Volume | MktCap |
|---|---|---|---|---|---|
| AXP | AXP Energy Ltd | 0.002 | 33% | 120,000 | $8,737,021 |
| IXC | Invex Ther | 0.49 | 27% | 200,138 | $28,934,231 |
| AVE | Avecho Biotech Ltd | 0.006 | 20% | 494,840 | $10,810,796 |
| DLI | Delta Lithium | 0.86 | 18% | 4,577,585 | $380,018,649 |
| ADS | Adslot Ltd | 0.0035 | 17% | 90,000 | $7,438,045 |
| RDN | Raiden Resources Ltd | 0.007 | 17% | 1,811,278 | $12,331,614 |
| KNI | Kuniko Ltd | 0.44 | 16% | 23,702 | $19,314,681 |
| ATP | Atlas Pearls Ltd | 0.045 | 15% | 2,136,626 | $16,686,999 |
| RDS | Redstone Resources | 0.008 | 14% | 12,500 | $5,802,149 |
| ROG | Red Sky Energy | 0.004 | 14% | 2,500,000 | $18,557,795 |
Biotech Invex Therapeutics (ASX:IXC) is on the winners list this morning after announcing the European Medicines Agency (EMA) for has granted Exenatide orphan drug designation (ODD) in the treatment of moderate to severe Traumatic Brain Injury (TBI).
IXC is focused on the development and commercialisation of Presendin (sustained release Exenatide) for neurological conditions relating to raised intracranial pressure.
This is the second ODD for Exenatide in Europe, with IXC receiving an ODD for Idiopathic Intracranial Hypertension (IIH) in 2017, alongside an ODD from the US Food and Drug Administration (FDA), also for IIH.
Delta Lithium (ASX:DLI) has announced the highest tenor intercept to date at its 100% owned Yinnetharra Lithium Project in the Gascoyne region of Western Australia and a major step out along strike in the M36 pegmatite which has currently been delineated over 1.7km.
The early-stage exploration project covers a large area of 505km2 within the Gascoyne Lithium Province of Western Australia.
- Six well defined mineralised pegmatites at Malinda
- Lithium mineralisation defined from surface to 350m depth so far
- Malinda boasts a ‘Lithium Mile’, comprising two major parallel ore zones M1 and M36 each now drilled out over 1.6km in strike length, remaining open down plunge.
New drilling results, both from M36 include:
- 33m @ 1.9% Li2O from 218m in YRRD118
- 19m @ 1.6% Li2O from 190m in YRRD114
“Yinnetharra is a big system, 216 holes in and we have pegmatites defined along 1.6km of strike, stacked in a package more than a kilometre wide,” executive chairman David Flanagan said.
“Mineralisation is open down plunge and it’s right here in Western Australia, the single biggest lithium producing region on the planet.”
LOSERS
Stocks highlighted in yellow have made market-moving announcements (click headings to sort).
| Code | Company | Price | % | Volume | Market Cap |
|---|---|---|---|---|---|
| ADY | Admiralty Resources | 0.006 | -25% | 7,607 | $10,428,633 |
| ICN | Icon Energy Limited | 0.003 | -25% | 28,500 | $3,072,055 |
| LNU | Linius Tech Limited | 0.003 | -25% | 480,000 | $15,061,829 |
| M4M | Macro Metals Limited | 0.003 | -25% | 99,999 | $7,948,311 |
| GTG | Genetic Technologies | 0.002 | -20% | 700,000 | $28,854,145 |
| XTC | Xantippe Res Ltd | 0.002 | -20% | 19,999,888 | $28,700,249 |
| AHI | Advanced Health | 0.210 | -16% | 600,770 | $54,300,992 |
| MRL | Mayur Resources Ltd | 0.115 | -15% | 615,438 | $42,097,626 |
| RIM | Rimfire Pacific | 0.006 | -14% | 165,006 | $14,036,713 |
| SI6 | SI6 Metals Limited | 0.006 | -14% | 2,310,717 | $10,467,762 |
